Summary of Purpose
To assess the safety and efficacy of intravenous thrombolysis with alteplase within 6 hours of stroke onset.Read More →
The following dates are available for this trial. Trial information last updated on 30 July 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, double-blind, controlled trial of 800 patients at 108 centers in Europe, Australia and New Zealand.